Elicio Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	20.61	17.62	12.89	6.16	9.28	14.97
Cash & Short-Term Investments	20.61	17.62	12.89	6.16	9.28	14.97
Cash Growth	-20.78%	36.64%	109.45%	-33.66%	-38.01%	119.78%
Prepaid Expenses	0.62	1.65	2.43	2.27	0.18	0.17
Restricted Cash	-	1.18	0.72	1.64	0.15	0.15
Other Current Assets	0.24	0.24	0.3	0.65	0.76	0.17
Total Current Assets	21.47	20.69	16.35	10.72	10.36	15.45
Property, Plant & Equipment	5.35	6.19	7.28	8.5	0.89	1.02
Other Long-Term Assets	1.47	1.3	3.52	3.45	3.57	3.18
Total Assets	28.28	28.18	27.15	22.66	14.81	19.66
Accounts Payable	0.32	1.04	4.37	2.81	1.68	1.65
Accrued Expenses	5.21	8.42	3.76	1.94	2.32	1.22
Short-Term Debt	-	-	-	-	11.8	-
Current Portion of Leases	0.98	0.9	0.91	0.69	-	0.44
Other Current Liabilities	-	1.17	0.72	1.44	3.09	-
Total Current Liabilities	6.52	11.52	9.76	6.87	18.88	3.31
Long-Term Debt	9.72	20.03	-	-	-	-
Long-Term Leases	4.36	5.11	6.01	6.79	-	-
Other Long-Term Liabilities	3.88	2.83	0.01	0.09	0.03	-
Total Liabilities	24.47	39.49	15.77	13.75	18.91	3.31
Common Stock	0.17	0.11	0.1	0	0.17	0.13
Additional Paid-In Capital	229.78	183	153.83	4.86	4.09	3.34
Retained Earnings	-225.95	-194.1	-142.2	-107.01	-78.8	-52.4
Treasury Stock	-0.15	-0.15	-0.15	-	-	-
Comprehensive Income & Other	-0.03	-0.18	-0.2	-	-	-0.21
Total Common Equity	3.82	-11.31	11.37	-102.15	-74.54	-49.14
Shareholders' Equity	3.82	-11.31	11.37	8.92	-4.1	16.35
Total Liabilities & Equity	28.28	28.18	27.15	22.66	14.81	19.66
Total Debt	15.06	26.04	6.92	7.48	11.8	0.44
Net Cash (Debt)	5.55	-8.42	5.98	-1.33	-2.52	14.53
Net Cash Growth	-	-	-	-	-	144.47%
Net Cash Per Share	0.37	-0.69	1.18	-4.19	-0.16	1.35
Filing Date Shares Outstanding	17.48	15.94	10.22	17.7	17.14	13.06
Total Common Shares Outstanding	17.26	11.03	9.6	17.7	17.14	13.06
Working Capital	14.95	9.17	6.59	3.85	-8.52	12.15
Book Value Per Share	0.22	-1.03	1.18	-5.77	-4.35	-3.76
Tangible Book Value	3.82	-11.31	11.37	-102.15	-74.54	-49.14
Tangible Book Value Per Share	0.22	-1.03	1.18	-5.77	-4.35	-3.76
Machinery	1.9	1.9	1.82	2.15	-	1.12
Leasehold Improvements	0.13	0.13	0.13	0.12	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q